New sensors developed to predict effectiveness of radiotherapy treatment
The human population is exposed to both natural and artificial sources...New sensor systems have now been developed that can assess the eff...The setup sends the external beam radiation from different angle...INVORAD developed two sensors that can perform the task in a sim...INVORAD also developed a cylindrical 'body phantom'. The 'phanto...
The human population is exposed to both natural and artificial sources of radiation, which can cause cancer and other defects. Strangely, the same radiation that causes such effects is used for the treatment of cancer, //referred to as radiotherapy. It is however very difficult to assess if the precise dose of radiation is being delivered.
New sensor systems have now been developed that can assess the effectives of the radiation treatment to improve the accuracy and reliability. The system called as Intensity Modulated Radiotherapy (IMRT) has been developed for real-time radiation monitoring.
The setup sends the external beam radiation from different angles to different regions of the tumor. A collimator modulates and shapes the beams so that the tumour receives a uniform dose. It improves clinical outcomes by more accurately targeting tumors and minimizing the amount of radiation absorbed by healthy tissue.
INVORAD developed two sensors that can perform the task in a simple way. The small size of the sensor, the response to different forms of radiation used in radiotherapy and compatibility of the device with microprocessors offer a superior advantage. The device is based on the working principle of semiconductor material that senses the incoming radiation and transmits it to a display unit.
INVORAD also developed a cylindrical 'body phantom'. The 'phantom' is given the prescribed dose and the sensors pick up the dose actually delivered. If the 'phantom' treatment matches the prescription of the simulator, the patient is given treatment. If not, the treatment plan needs to be corrected.
The two devices are being tested in patients undergoing radiotherapy treatment. If successful, there would soon be commercialization of the sensor system. This is hoped to reduce the side effects patients associated with radiotherapy by improving accuracy of dose delivery, which has a significant impact in cancer tr '"/>
(Date:11/26/2009)...wswire/ -- The diabetes population in the United S...d annual medical spending on the disease is projec...y, according to a study published in the December ...Diabetes ® Program (NCDP), a program of Novo ...the University of Chicago. ,, According to the ...
(Date:11/26/2009)... to strains or worse , , THURSDAY, Nov. ...with stuffing your turkey full to bursting, but yo...itcase as you pack for holiday trips. , More th...ital emergency rooms, doctors, offices, clinics an...uries, such as muscle strains, pulls and tears, ac...
(Date:11/26/2009)...he Live Life Again Center, a practice offering we...number of physicians who are taking advantage of ...dividuals who are interested in surgical weight lo...tilizing Facebook to share before-and-after photos...nity. , Dallas, TX (Vocus...
(Date:11/26/2009)... P.A. is offering free nationwide confidential con...ol pills who have suffered a Deep Vein Thrombosis ... other related cardiac issues or had their Gallbla...6-6405 or go to the firm’s website at http:...aluation form. , (PRWEB) ...
(Date:11/25/2009)...RNewswire-FirstCall/ -- Onyx Pharmaceuticals, In...ny will host two investor events in December: ,...0 a.m. CT/10:00 a.m. ET ,, Principal investig...carfilzomib in relapsed and/or refractory multiple... of Hematology (ASH) Annual Meeting and Exposition...
... number of patients in need of organ transplants o...urning to unconventional sources for organs. Indiv...ancial incentive, particularly in developing count...of a session during the American Society of Nephro...
... Nov. 7 Ninety years ago today,the guns fell sile...rs" -,was over. Almost five million Americans serv...st living link with them, 107-year-old Army vetera...ice and sacrifice of our veterans, from Mr. Buckle...
...v. 7 The Chicago Cubs were presented with,the 200...Runaway,Switchboard,s ( http://www.1800runaway.org...cago., The "Spirit of Youth" award recognizes ind...by Cory Provus, one of,the team,s radio announcers...
...y Services Now Taking Part, WASHINGTON, Nov. 7 W...ave easier, quicker access to their veterans,benef...ill offer,streamlined disability evaluations that ...f the Disability Evaluation System (DES) pilot whi...
...he protection and keeping the trust of our members.... 7 AARP CEO Bill Novelli,issued the following re...ontaining questions about the marketing and sales ...OGO ), "Ensuring the protection and keeping the t...
... (Nov. 7, 2008) -- Leading fertility experts at Ne...dical Center are presenting new research findings ...e Medicine (ASRM) meeting in San Francisco, Nov. 8...ty Care." He will speak on "Clinical Paradigms Gai...
(Date:11/25/2009)... , RANCHO CORDOVA, Calif., Nov. 25 /PRNewswire...of American Pacific Corporation (Nasdaq: APFC ) a...Responsibility and Sustainability Award at the Ann...he California Manufacturers and Technology Associa...ion (IEA) and the Chemical Industry Council of Cal...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Rep... report is available in its catalogue: ,, Unit...asts to 2015 ,, http://www.reportlinker.com/p...is-and-Forecasts-to-2015.html ,, United States...015 ,, Summary ,, This report is an essent...
(Date:11/25/2009)... , EAST BRUNSWICK, N.J., Nov. 25 /PRNewswir...acturer of direct digital Radiography ( ddR ) syst... acquired by a private Swiss Investor with a long ...ng brand. The acquisition included all assets and ...ventory. After 25 years of success and growth Swis...
...atment of Patients with Relapsed/Refractory Walde... Tomorrow, Tuesday, June 3rd at 12:00pm in Room E...Inc. (Nasdaq: KERX ) today announced that abstrac...cted for both poster presentation and,publication ...eeting,currently taking place in Chicago, Illinois...
... 2 ,Bayer HealthCare Pharmaceuticals, Inc. and Ony...ounced the presentation of new clinical data from,...am for Nexavar(R),(sorafenib) tablets in multiple ...arian cancers. Nexavar is currently approved in mo... with unresectable liver cancer and,in more than 7...